Search
for
Sort by
Research 91–120 of 962
- A novel therapeutic paradigm for patients with extensive alopecia areata
- New drugs under investigation for the treatment of alopecias
- Cicatricial alopecia
- Male fertility and skin diseases
- Perspectives in dermatopathology: telomeres and telomerase in ageing and cancer; with emphasis on cutaneous disease
- To evaluate the role of interleukin-6 in alopecia areata
- Differential impact of environmental factors on systemic and localized autoimmunity
- The spectrum of nephrocutaneous diseases and associations
- Darier Sign: A Historical Note
- Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
- Cronkhite-Canada Syndrome: A Case Report
- Differences in cell subsets between sun-exposed and unexposed skin: preliminary single-cell sequencing and biological analysis from a single case
- Aberrant inflammasome activation as a driving force of human autoimmune skin disease
- Can the Second to Fourth Digit Ratio (2D : 4D) Be a Marker to Determine Ankylosing Spondylitis Disease Activity?
- Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- ESGCT and FSGT Collaborative Congress Helsinki, Finland September 17–20, 2015 Abstracts
- Atlas of Geriatric Dermatology
- Antihelminthic Drugs
- Updates from the British Association of Dermatologists 91st Annual Meeting, 5-7 July 2011, London, U.K.
- A consensus-based treatment algorithm for alopecia areata in adolescents and adults: integrating severity, quality of life, and disease dynamics
- Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA
- Narrative Review of Skin and Pregnancy: Dermatologic Manifestations and Medication Management During Pregnancy
- Geriatric Dermatologic Therapy
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Serum level of calprotectin as a new inflammatory marker in patients with alopacia areata
- Das weiße Hautfettgewebe initiiert die IL-33-abhängige Expression von Interleukin 4/13 in myeloischen Zellen während einer Entzündung
- Dermatolojik Problemler ve COVID-19
- Pattern of Skin disorders across age groups